SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
195.00    10.00 (5.41%)
Bid:
190.00
Ask:
200.00
Spread: 10.00 (5.263%)
Market Cap: £113.24m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

PDMR Dealings - amendment

3 Oct 2022 18:12

RNS Number : 6301B
Focusrite PLC
03 October 2022
 

For immediate release

 

An amendment has been made to the RNS announcement number 8706T released on 29 November 2021 at 09:48:53.

The following correction has been made to Tim Dingley's total shareholding in the fourth paragraph. 

The text now reads:

"Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital."

All other details remain unchanged. The full amended text is show below.

 

 

 

 

PDMR Dealings

FOCUSRITE PLC

Released 09:48:53 29 November 2021

 

RNS Number : 8706T

Focusrite PLC

29 November 2021

 

Focusrite plc

 

("the Company" or "the Group")

 

 PDMR Dealings

Settlement of Share Options

 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 25 November 2021 Tim Dingley, a Person Discharging Managerial Responsibilities ("PDMRs"), exercised nominal cost options over 15,919 shares granted to him under the Company's Performance Share Plan and acquired ordinary shares of 0.1p each in the Company.

 

The option was granted on 21 November 2018 and became vested and exercisable as from 22 November 2021.

 

The exercise of the option was settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option.

 

Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

 Tim Dingley

2

Reason for the notification

a)

Position/status

 Chief Operating Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s) and volume(s)

 

Price(s)

Volumes

£ 15.92

15,919 (settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 15,919 shares)

 

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

4B

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Transfer of shares to Janice Dingley (spouse) for nil consideration

c)

Price(s) and volume(s)

 

Price(s)

Volumes

Nil

8,437

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

 

 

 

-ends-

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin

William Brinkley

Charlotte Young

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

 

Michael Burke

 

James Smith

 

Belvedere Communications

John West

+44 20 3687 2753

Llew Angus

+44 20 3687 2754

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPGBUUUPPGMW
Date   Source Headline
9th Mar 20221:25 pmRNSTR-1
1st Mar 20224:42 pmRNSSecond Price Monitoring Extn
1st Mar 20224:36 pmRNSPrice Monitoring Extension
25th Jan 202211:11 amRNSTR-1
17th Dec 202112:27 pmRNSResult of AGM
17th Dec 202110:38 amRNSBoard Changes, Appointment of New NED
17th Dec 20217:00 amRNSAGM Statement and Update on Trading
8th Dec 20211:18 pmRNSNotification of PDMR Transactions
29th Nov 20219:48 amRNSPDMR Dealings
25th Nov 20212:37 pmRNSPDMR Dealings
23rd Nov 20217:00 amRNSTR-1
19th Nov 20214:30 pmRNSGrant of Share Options to PDMRs
19th Nov 20214:25 pmRNSDirector Share Dealings
16th Nov 20217:00 amRNSFinal Results
2nd Nov 20217:00 amRNSNotice of Final Results
13th Oct 20217:00 amRNSChange of adviser
14th Sep 20217:00 amRNSTrading Statement
20th Jul 20217:00 amRNSTrading Statement
14th Jul 20213:56 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSIssue of Management Shares
6th May 20217:00 amRNSPayment of Interim Dividend
4th May 20217:00 amRNSDirector/PDMR Shareholding
27th Apr 20217:01 amRNSHalf Year Results
27th Apr 20217:00 amRNSAcquisition of Sequential LLC
20th Apr 20217:00 amRNSLaunch of New Brand: Optimal Audio
9th Apr 202110:33 amRNSNotice of Interim Results
1st Mar 20217:00 amRNSDirectorate Change
19th Feb 20217:00 amRNSTrading Update
5th Jan 20214:28 pmRNSNotification of PDMR Transactions
24th Dec 20207:00 amRNSShare issuance to EBT
23rd Dec 20206:09 pmRNSTR-1
23rd Dec 202012:08 pmRNSSettlement of Share Options
22nd Dec 20204:07 pmRNSCompletion of Secondary Placing of Shares
22nd Dec 202012:00 pmRNSProposed Secondary Placing of Shares
17th Dec 202012:22 pmRNSResult of 2020 AGM
17th Dec 20207:00 amRNSAGM Statement and Update on Trading
15th Dec 202010:50 amRNSSettlement of Share Options
4th Dec 20202:52 pmRNSSettlement of Share Options
1st Dec 20203:47 pmRNSSettlement of Share Options
25th Nov 20206:02 pmRNSNotification of PDMR Transactions
19th Nov 20203:54 pmRNSDirectors’ Dealings
18th Nov 20201:57 pmRNSDirector Share Dealings
17th Nov 20207:00 amRNSFinal Results for the Year Ended 31 August 2020
4th Nov 20207:00 amRNSNotice of Final Results
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20202:06 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.